ANDREW SELTZER: Open Payments
NPI 1811079338 · VAN NUYS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,106 in 57 payments from 17 companies in 2025. Trend: 2023 $2,938 · 2024 $1,612 · 2025 $1,106
Food & beverage: $1,106
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 18 | $298 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $151 |
| Lundbeck LLC | 4 | $110 |
| Abbott Laboratories | 4 | $84 |
| MML US, Inc. | 3 | $68 |
| Virtus Pharmaceuticals LLC | 3 | $68 |
| Spinal Simplicity, LLC | 2 | $54 |
| IBSA Pharma Inc. | 2 | $40 |
| Medtronic, Inc. | 1 | $40 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $33 |
Products named: Belbuca, RELISTOR, VYEPTI, ReActiv8, LEVORPHANOL TARTRATE, PROCLAIM, HA MINUTEMAN G3-R, XTAMPZA.
Industry payments across CA — which companies pay providers there.
